The Daily Papule

Clin DermReview

Paraneoplastic dermatoses in patients with hematologic malignancy.

Singhaviranon S, Klufas T, Aiudi D

Clinics in DermatologyIn the feed 28 Jul 2026, published online 28 Jul 2026, issue 2026 Sep-Oct, added to PubMed 28 Jul 2026

Topics: Autoimmune & connective tissueNeutrophilic, granulomatous & autoinflammatorySkin signs of systemic disease

Abstract

Malignancies can elicit a vast array of systemic findings in patients that are not directly driven by tumor invasion. These paraneoplastic syndromes may result from mechanisms ranging from ectopic hormone expression to crossreactive immune responses. Many of these paraneoplastic syndromes can even resemble autoimmune dermatoses. Paraneoplastic dermatoses are especially common in patients with hematologic malignancies. We review the fundamental mechanisms underlying immune-mediated paraneoplastic dermatoses in patients with hematologic malignancies and describe several common paraneoplastic dermatoses including some neutrophilic dermatoses (Sweet's syndrome, pyoderma gangrenosum, subcorneal pustular dermatosis/IgA pemphigus), eosinophilic dermatoses and paraneoplastic pemphigus) that can be found in patients with hematologic malignancies.

Abstract from PubMed

PMID 42521048 · DOI 10.1016/j.clindermatol.2026.07.021

Comments